Search

everythinglearnresearchcommunity

for

Search:↓

Oral Apremilast effectively treats alopecia areata in most patients.

Platelet-rich plasma and microneedling could potentially help hair growth in people with alopecia areata, but more research is needed.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

The document concludes that various hair and scalp disorders in children have specific treatments and proper diagnosis is essential.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Current alopecia treatments manage symptoms but don't cure, and better treatments are needed.

Lamivudine might reverse hair graying and needs more research for potential treatments.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Some plants with flavonoids may help treat hair loss and promote hair growth.

The document is a detailed guide on skin conditions and treatments for dermatologists.

Transethosomes improve drug delivery through the skin and show promise for treating various conditions.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Platelet-rich plasma and microneedling could potentially help hair regrowth in alopecia areata patients, but more research is needed.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

Sinsun-yukza-hwan extract promotes hair growth in mice.

Hydroxychloroquine may help treat alopecia areata in children.

Outside factors like grooming, chemicals, and the environment can damage hair and cause disorders.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.